| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.21288 |
| P698 | PubMed publication ID | 16200609 |
| P50 | author | Tebeb Gebretsadik | Q90344341 |
| P2093 | author name string | Paolo Raggi | |
| Theodore Pincus | |||
| Tuulikki Sokka | |||
| Annette Oeser | |||
| C Michael Stein | |||
| Cecilia P Chung | |||
| Ayumi K Shintani | |||
| Ingrid Avalos | |||
| P433 | issue | 10 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 3045-3053 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors | |
| P478 | volume | 52 |
| Q35139150 | A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study |
| Q52587395 | Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity. |
| Q87477294 | Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study |
| Q33950766 | Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. |
| Q37255236 | Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis |
| Q34021686 | Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis |
| Q36984426 | Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis |
| Q37721221 | Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature. |
| Q37331767 | Aspirin use in rheumatoid arthritis patients with increased risk of cardiovascular disease |
| Q48263351 | Association between urinary sodium and potassium excretion and blood pressure and inflammation in patients with rheumatoid arthritis |
| Q42367098 | Association of Metabolic Syndrome in Chronic Plaque Psoriasis Patients and their Correlation with Disease Severity, Duration and Age: A Case Control Study from Western Maharashtra |
| Q37179297 | Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis |
| Q37658803 | Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus |
| Q36726386 | Atherosclerosis and inflammation: insights from rheumatoid arthritis |
| Q34153114 | Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness |
| Q92104941 | Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis |
| Q55413719 | Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. |
| Q36928407 | C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis |
| Q48110781 | Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy |
| Q88599465 | Can we predict thrombotic tendency in rheumatoid arthritis? A thromboelastographic analysis (with ROTEM) |
| Q50355546 | Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases. |
| Q33943374 | Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment |
| Q36218375 | Cardiovascular disease and rheumatoid arthritis: an update |
| Q36757060 | Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study |
| Q37808570 | Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications |
| Q26739070 | Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers |
| Q82835412 | Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model |
| Q99593408 | Circulating microbial small RNAs are altered in patients with rheumatoid arthritis |
| Q33579891 | Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey |
| Q34751297 | Comparison of the atherosclerotic burden among asymptomatic patients vs matched volunteers |
| Q37246482 | Coronary Artery Calcification Is Related to Inflammation in Rheumatoid Arthritis: A Long-Term Follow-Up Study |
| Q40556371 | Coronary Artery Calcification and Rheumatoid Arthritis: Lack of Relationship to Risk Alleles for Coronary Artery Disease in the General Population |
| Q37206907 | Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis |
| Q35557952 | Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease |
| Q35511202 | Cystatin C, renal function, and atherosclerosis in rheumatoid arthritis |
| Q21202033 | Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients |
| Q37292191 | Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors |
| Q57178937 | Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months |
| Q40959053 | Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis |
| Q49282700 | Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial |
| Q34773899 | Epicardial fat thickness as cardiovascular risk factor and therapeutic target in patients with rheumatoid arthritis treated with biological and nonbiological therapies. |
| Q37930979 | Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians |
| Q88915778 | Exercise is Associated With Increased Small HDL Particle Concentration and Decreased Vascular Stiffness in Rheumatoid Arthritis |
| Q34238357 | Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity |
| Q39331236 | Fcγ receptor III and Fcγ receptor IV on macrophages drive autoimmune valvular carditis in mice |
| Q35581083 | Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis |
| Q35921093 | Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis |
| Q38680931 | High-density lipoprotein function in rheumatoid arthritis |
| Q28480869 | High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation |
| Q38164341 | If there is an evolutionary selection pressure for the high frequency of MBL2 polymorphisms, what is it? |
| Q34187954 | Impact of serum amyloid A on high density lipoprotein composition and levels |
| Q92708651 | Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration |
| Q35086458 | Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis |
| Q37281848 | Inflammation and hypertension in rheumatoid arthritis |
| Q37371379 | Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms |
| Q33686973 | Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis |
| Q34104339 | Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis |
| Q37699878 | Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis |
| Q34910792 | Lipid profile and metabolic syndrome status in patients with oral lichen planus, oral lichenoid reaction and healthy individuals attending a dental college in northern India - a descriptive study |
| Q34037325 | Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis |
| Q35489690 | Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis |
| Q34486477 | Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis |
| Q51119389 | Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis. |
| Q38098935 | Novel risk factors for cardiovascular disease in rheumatoid arthritis |
| Q36245756 | Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: a cross-sectional study |
| Q37124549 | Oxidative stress in fibromyalgia and its relationship to symptoms |
| Q24235180 | Pain management for rheumatoid arthritis and cardiovascular or renal co-morbidity |
| Q24235971 | Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity |
| Q37328983 | Perceived and actual risk of cardiovascular disease in patients with rheumatoid arthritis in Korea: A cross-sectional study |
| Q37690079 | Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial |
| Q36511541 | Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis |
| Q37690404 | Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis |
| Q89121860 | Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis |
| Q34098318 | Reversing vascular dysfunction in rheumatoid arthritis: improved augmentation index but not endothelial function with peroxisome proliferator-activated receptor γ agonist therapy |
| Q38794852 | Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity? |
| Q36843132 | Rheumatoid arthritis and atypical cardiovascular disease: inflammation changing the clinical presentation |
| Q92442225 | Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis |
| Q36326701 | Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis |
| Q35257568 | Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis |
| Q37027316 | Statin treatment for rheumatoid arthritis: a promising novel indication |
| Q93083351 | Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study |
| Q35154761 | Systemic inflammation and early atheroma formation: are they related? |
| Q37689488 | Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins |
| Q42385423 | Telomere Length and Coronary Atherosclerosis in Rheumatoid Arthritis |
| Q47878182 | Ten-year progression of coronary artery, carotid artery, and aortic calcification in patients with rheumatoid arthritis. |
| Q92493110 | The Endogenous Plasma Small RNAome of Rheumatoid Arthritis |
| Q36610558 | The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A. |
| Q55285084 | The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox |
| Q34388576 | The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis |
| Q35204645 | The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores |
| Q35230117 | The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients |
| Q36245657 | The lp13.3 genomic region -rs599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis. |
| Q50722036 | The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis. |
| Q37377251 | The same systemic autoimmune disease provokes arthritis and endocarditis via distinct mechanisms. |
| Q37817050 | The swollen joint, the thickened artery, and the smoking gun: tobacco exposure, citrullination and rheumatoid arthritis |
| Q36027291 | Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. |
| Q36577503 | Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis |
| Q34109156 | Total calcium-sensing receptor expression in circulating monocytes is increased in rheumatoid arthritis patients with severe coronary artery calcification |
| Q35251472 | Urinary albumin excretion is increased in patients with rheumatoid arthritis and associated with arterial stiffness |
| Q89647402 | Utility of Coronary Calcium Scoring (CCS) in Connective Tissue Disorders (CTDs) for the Evaluation of Subclinical Coronary Atherosclerosis - A Systematic Review |
| Q36117792 | Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis |
| Q35652911 | Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis |
| Q35630128 | Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis |
| Q34164481 | Validated methods for assessment of subclinical atherosclerosis in rheumatology |
| Q84774582 | [Coronary calcification and subclinical myocardial dysfuncion in rheumatoid arthritis] |
Search more.